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Abstract
Many prescription medications can either directly or indirectly interact with alcohol and
many chronic conditions may be worsened by alcohol use. Medications, such as
antihypertensives, anticoagulants, and gastrointestinal agents, can be dangerous when taken
with alcohol and can lead to loss of consciousness, falls, serious bleeding and other issues.
Chronic conditions, such as gastroesophageal reflux disease, hypertension and cirrhosis can
directly be worsened with alcohol consumption. These potential complications are pertinent to
all ages, but there is greater concern of these interactions in older adults, defined as adults over
65 years old. Using survey data from older adults in Lexington, KY, descriptive statistics were
used to analyze the prevalence of alcohol-interactive medications and alcohol-interactive
disease states with concurrent alcohol use in this population.
The aim of this study was to investigate older adults in Kentucky using medications that
that interact with alcohol or have disease states that can be worsened or caused by alcohol.
These findings could help determine if there is a gap in care regarding this issue. If a gap in care
is identified, then possible interventions to make, such as re-structuring pharmacist alcohol
screening to include these interactions, will be investigated and a need for further research will
be determined.

Executive Summary
The primary objective of this study was to identify the prevalence of alcohol-interactive
medications and alcohol-interactive conditions with concurrent alcohol use in older adults.
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Survey data from 2020 of older adults in Lexington was used to derive descriptive statistics and
identify the prevalence of these interactions. The descriptive statistics included number of
alcohol-interactive medications reported, number of alcohol-interactive conditions reported,
and alcohol use reported as number of drinks per week or number of drinks per month.
Of the study participants surveyed, 62/92 (57%) reported being current drinkers. In
addition, 100% reported taking an alcohol-interactive medication and 100% reported an
alcohol-interactive medical condition. Furthermore, the average number of alcohol-interactive
medications reported was 4.29 +/- 1.91. The average number of alcohol-interactive disease
states reported amongst participants was 2.35 +/- 1.01. The highest risk participants are those
who consume alcohol the most frequently and reported taking a high number of alcoholinteractive medications and having a high number of alcohol-interactive disease states. Thus,
18/92 (19.6%) participants reported taking 4 or more alcohol-interactive medications and
drinking 3 or more drinks per week. In contrast, only 6/92 (6.5%) participants reported having 4
or more alcohol-interactive disease states and having 3 or more drinks per week. The most
commonly report alcohol-interactive medications were anticoagulants and antihypertensives.
The most reported alcohol-interactive medical conditions were hypertension gastroesophageal
reflux disease.
This study found that there is a significant number of older adults in the Lexington area
that take alcohol-interactive medications or have alcohol-interactive disease states and are
concurrent drinkers. There is also a smaller prevalence of older adults who are very high risk of
interactions, as they reported drinking frequently and having a high number of alcohol-
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interactive medications and disease states. These interactions pose health concerns for this
demographic and ways to address this issue needs to be investigated further.

Background
It has been well established that alcohol has the potential to cause a wide variety of
health issues. In the Global Status Report on Alcohol and Health 2018, the World Health
Organization outlined over 200 health conditions in which alcohol plays a role in causing or
worsening in some way. Some of these health conditions include liver disease, heart disease
and pancreatitis (WHO, 2018). Not only can alcohol use potentially lead to the development of
these health conditions, but it can also exacerbate existing health conditions. Some examples of
conditions that may be exacerbated by alcohol use include dementia, gastrointestinal bleeds,
and orthostatic hypotension, among others (WHO, 2018). The risk of alcohol use doesn’t stop
there, as there are many medications that alcohol directly interacts with when taken together.
There is potential for medications to alter the metabolism of alcohol, which could lead to
increased levels of alcohol in the body and greater cognitive impairment, and there is potential
for alcohol to alter the metabolism of other medications, which could cause the medication to
be present at subtherapeutic or toxic levels in the body (Weathermon et al., 1999).
The potential complications described above are important to monitor in all individuals,
but especially in older adults, which is defined in most cases as people over the age of 65 years.
Older adults are at increased risk of falls, dementia, major bleeds, and heart disease. Not only
can these health issues be exacerbated when combined with alcohol use, but the medications
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that are commonly prescribed for some of these disease states can directly interact with
alcohol as well.
The prevalence of alcohol use in older adults is estimated to be high. A recent study
estimated that 65% of Americans over the age of 65 are high-risk drinkers (Grant et al., 2017),
while another study that looked at drinking behaviors of older adults estimated that 10.6% of
older adults are classified as binge drinkers (Han et al., 2019). In addition to the risks associated
with alcohol use alone in older adults, there is data showing that Americans over the age of 65
are the highest risk demographic in terms of taking a medication that interacts with alcohol
(Breslow et al, 2015). Given the high estimated prevalence of alcohol use and high risk of
complications in older adults, this health issue remains pertinent and is an area where
interventions can be made.

Literature Review
There are many studies that have investigated alcohol-interactive medications, but a
lack of a consensus list of medications that negatively interact with alcohol. For example, a
systematic review of alcohol-interactive medications and alcohol in older adults performed by
Holton et al. (2017) found that out of nine different studies, there was no consistent list of
medications that researchers for each study deemed “alcohol-interactive”. This lack of
consensus was a major limitation of this systematic review and led to a less reliable estimate of
incidence of concurrent medication use with alcohol in older adults. This review estimated that
incidence of concurrent use of alcohol and alcohol-interactive medications in older adults was
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between 21% - 35%. This study shows that there is a significant incidence of concurrent use, but
further studies need to be done to compile a universal list of alcohol-interactive medications.
One trial attempted to fill this gap in knowledge. In 2015, Breslow et al. conducted a large study
investigating the use of alcohol-interactive medications and current drinkers. This study used
data from the National Health and Nutrition Examination Survey (NHANES) from 1999-2010 and
analyzed the medications and alcohol use of 26,657 adults over the age of 20 years. This study
expanded on the only previous study to investigate alcohol-interactive medication use at a
national level, conducted by Jalbert et al (2008). Jalbert et al. focused on medications that can
alter the metabolism of alcohol and intensify its effects, which is now thought to only be part of
the concern. Breslow et al. created a list of medications using multiple different publications
and online resources, and found that there were many more alcohol-interactive medications
than just those that intensify the effects of alcohol. Their study stratified participants based on
age, and they found that among older adults who were current drinkers, 77.8% used alcoholinteractive medications.
This study demonstrated an issue with older adult drinkers and concurrent alcoholinteractive medications use, but it remains to be seen whether any changes in prevention or
screening have occurred since this study. Currently, the US Preventative Services Task Force
recommends screening for adults over the age of 18 years for alcohol misuse or abuse (Moyer,
2013). The issue is that this screening is only aimed toward risky behaviors associated with
alcohol abuse. The important distinction to make is that older adults don’t need to abuse
alcohol to have serious consequences if they are taking an alcohol interactive medication. Even
low levels of alcohol in an older adult's body can interact with their medication and cause
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potentially life-threatening complications. Thus, current screening recommendations fail to
address a demographic of patients that should be screened.
Recent literature suggests that framing alcohol screening in terms of how alcohol use
can interact with current medications may result in patients more willing to quit alcohol or limit
its use when taking an alcohol-interactive medication. For example, a study performed by
Madden et al. (2019) evaluated a small population of adults and their willingness to discuss
their alcohol use with a community pharmacist. The authors found that 23/25 of these adults
who drink alcohol at varying levels were more open to the idea of discussing alcohol use with
their pharmacist if it relates to their medications or medical conditions. One participant stated
“Link it to the medication because that’s why I’m there in the first place. That would be my
expectation. If they ask me just as a general…I’d think, well, what’s it got to do with you?”
(Madden et al., 2019). This participant highlights that addressing alcohol use as a lifestyle
intervention may cause more defensive patients than addressing alcohol use as a medication or
medical condition issue. Screening patients for alcohol in terms of alcohol-interactive
medications would not only reach a large population of drinkers, but also may appear less
judgmental and result in more successful interventions.
Currently, alcohol and substance use interventions are mainly performed by primary
care physicians. A 2017 study showed that for patients ages 20 and up, an average time of 65.8
minutes was spent with their primary care physician per year. This may highlight a gap in care,
as thorough alcohol use intervention likely can’t happen in that short period of time. There is a
role for community pharmacists to play in this gap in care, as community pharmacists spend
much more time face-to-face with patients than primary care physicians.
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Methods
The purpose of this study was to investigate a population of adults in Lexington, KY over
the age of 65 and analyze their medication list, past medical history, and average alcohol use to
determine the prevalence of alcohol-interactive medications and disease states. This study was
a post-hoc analysis of the INtervention for Cognitive Reserve Enhancement in delaying the
onset of Alzheimer’s Symptomatic Expression (INCREASE) trial. The INCREASE trial evaluated
older adults in Lexington to determine if medication therapy management services would have
an impact on medication inappropriateness amongst this population, in hopes of reducing the
rate of cognitive decline in these adults and slow progression to dementia. The INCREASE trial
enrolled 104 adults in Lexington, KY over the age of 65. The study population can be described
as adults over the age of 65 who are non-demented, community-dwelling, medically stable and
report taking at least one medication on BEERS 2015 criteria list (J Am Geriatr Soc 2015). BEERS
2015 criteria list is a list of medications deemed potentially harmful in the elderly. All
participants completed a lifestyle questionnaire, which included questions regarding average
alcohol use. Other pertinent data collected includes a full list of their prescription and nonprescription medications and a full list of their past medical history.
Participants were electronically logged using a RedCap survey, which included alcoholuse status, number of alcohol-interactive medications, number of alcohol-interactive disease
states and Charleston comorbidity index. RedCap is a platform which allows researchers to log
data and export the data into various programs for data analysis.
INCREASE trial participants reported alcohol use on the lifestyle questionnaire as one of
the following categories: never or less than once per month, 1-3 per month, 1 per week, 2-4 per
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week, 5-6 per week, 1 per day, 2-3 per day, 4-5 per day or 6+ per day. They reported their
usage for beer, liquor and wine individually. Given the scope of the INCREASE trial lifestyle
questionnaire, alcohol use for this study was described as “non-current drinker” if participants
reported never drinking or drinking less than one drink per month, “current drinker” if
participants reported drinking one or more drink per month, and “frequent drinker” if
participants reported drinking 3 or more drinks per week.
The National Institute of Alcohol Abuse and Alcoholism (NIAAA) defines alcohol use
differently than the scope of this study. The NIAAA defines moderate drinking as 2 or fewer
drinks per day for men and 1 or fewer drinks per day for women. The NIAAA defines heavy
drinking as more than 4 drinks on any day or more than 14 drinks per week for men, and more
than 3 drinks on any day or more than 7 drinks per week. (Dietary Guidelines for Americans,
2020-2025). These definitions are appropriate for alcohol abuse, but do not accurately depict
risky drinking behaviors as they relate to interactions with medications and disease states, as
even small amounts of alcohol consumption could cause adverse interactions. Thus, alcohol use
is defined differently for this study.
Medications that are described as alcohol-interactive include central nervous system
agents, cardiovascular agents, anticoagulants, gastrointestinal agents, antidepressants,
antipsychotics antihyperglycemic agents and antihistamines. When taken with alcohol, these
medications may cause increased sedation, dizziness, increased risk of gastrointestinal
bleeding, hypoglycemia, seizures, hypotension, insomnia, and worsening depression.
Collaboration with pharmacists at University of Kentucky Healthcare was utilized to determine
a comprehensive list of these medications for comparison in our study population.
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Disease states or medical conditions that have the potential to be caused by alcohol or
exacerbated by alcohol include central nervous system depression (fall risk), gastrointestinal
bleeds and irritation, hypotension (fall risk), seizures, hypertension, gout, insomnia, depression,
liver disease, and breast cancer. Similarly, pharmacists at University of Kentucky Healthcare
were consulted to determine a list of disease states that are deemed alcohol-interactive, for a
consensus list does not exist in the literature.

Results
For this study, 92 participants were analyzed, as 12 participants from the INCREASE trial
did not give responses to the alcohol use portion of the questionnaire and will not be pertinent
to this study. Of the 92 participants, 40/92 (43%) of participants reported never drinking or
drinking less than 1 drink per month and were classified as non-current drinkers, 62/92 (57%) of
participants reported drinking one or more drinks per month and are classified as current
drinkers, and 30/92 (33%) of participants reported having more than three drinks per week and
are classified as frequent drinkers.
Of the 92 participants included in this study, 100% reported taking an alcoholinteractive medication and 100% reported an alcohol-interactive medical condition. The
average number of alcohol-interactive medications reported was 4.29 +/- 1.91. The average
number of alcohol-interactive disease states reported amongst participants was 2.35 +/- 1.01. A
total of 18/92 (19.6%) participants reported taking 4 or more alcohol-interactive medications
and drinking 3 or more drinks per week. Only 6/92 (6.5%) participants reported having 4 or
more alcohol-interactive disease states and having 3 or more drinks per week. The most
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commonly report alcohol-interactive medications were anticoagulants and antihypertensives.
The most reported alcohol-interactive medical conditions were hypertension and
gastroesophageal reflux disease.

# of AI medications

Non-current
drinker

Current drinker

Frequent drinker

Total

1-3

19

7

12

38

4-6

13

13

15

41

7-9

8

2

3

13

Total

40

22

30

92

Table 1: Alcohol-interactive (AI)-med frequency distribution

# of AI conditions

Non-current
drinker

Current drinker

Frequent drinker

Total

1

11

3

4

18

2

13

11

14

38

3

12

6

6

24

4

3

2

4

9

5

1

2

3

Total

40

30

92

22

Table 2: Alcohol-interactive (AI)-condition frequency distribution

BEERS list medications are thought of as medications that should be used with caution
in the elderly population, as they may potentiate a number of adverse effects, such as
hypotension, falls, and gastrointestinal bleeding. The number of alcohol-interactive medications
can be compared to the average number of BEERS list medications, which is 2.47 for this study
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population, indicating that alcohol-interactive medications may be even more prevalent than
BEERS list medications and warrant more in-depth screening. Of note, the total number of
medications that are both on the BEERS criteria list and the alcohol-interactive list was 29/221
(13.9%) for this study population.

Discussion
This study had multiple limitations. First, the study was limited using another study’s
data. The INCREASE trial surveyed participants with very specific questions, much of which
could not be utilized in this study. In addition to all the INCREASE trial survey questions not
being able to be used, there were certain questions that would have been very pertinent to this
study that were unable to be used because the survey was already completed, and the
participants could not be reached. This limitation prevented the study from investigating this
issue further through more thorough survey questions and follow up surveys. These missing
components should be of interest in future studies, as follow up surveys would allow
researchers comparative data to analyze.
Another limitation of this study was that the measure of alcohol use was not as precise
as it ideally would have been. Ideally, this study would have been able to analyze exactly how
many were “never drinkers”, but the survey phrased the question as “never or less than 1 per
month”. Having more specific information would help us identity a likely high number of
“current drinkers”. With more accurate drinking frequency, researchers could better
differentiate high and low risk of interactions by looking at specific drinking times and
medication administration times.
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The study was also limited by the fact that one of the inclusion criteria for the patient
population in the INCREASE trial was that they had to have at least 1 medication that is on the
BEERS list. The BEERS list contains nearly 100 medications that are deemed to be potentially
harmful for the elderly. Some of these medications also are included on the alcohol-interactive
medication list, so the prevalence of older adults using alcohol-interactive medications in this
study may be overestimated.
Lastly, this post-hoc analysis was limited as it investigated 92 older adults in Lexington,
KY. This study is unable to be universally applied to the general population because of the small
scope of this local study. In addition, the scope of this study only included 1 time point. It would
be valuable to know how study participants compare prior to a proposed intervention over a
longitudinal period. Future studies should attempt to broaden the scope of this study by
including national data and a longer trial period to determine the broader prevalence of this
issue.
This study identified a significant health concern in this patient population. It can be
debated whether this study underestimates or overestimates the prevalence of these issues.
The limitations mentioned previously may overestimate the prevalence of these issues.
However, adults who volunteer for clinical studies are often healthier individuals, so this patient
population may underestimate the broader prevalence of these health concerns.

Policy Implications
Current efforts to address alcohol use in older adults are framed around alcohol abuse
and addiction. This framework misses a large portion of these adults and fails to address the
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negative side effects that can happen even when drinking alcohol in moderation. The
prevalence of alcohol interactions identified in this study provides insight into a need for new
policy changes in healthcare systems and pharmacies.
Pharmacy students are educated in alcohol abuse counseling as a part of medication
therapy management interviews. During these interviews, pharmacy students ask patients
about medications, past medical history, and social history, which includes alcohol, tobacco,
and illicit substance use. However, there is little education on how to address alcohol use unless
patients are heavy drinkers and suffering from addiction. All the information that is needed
from patient interviews is currently being asked, but we are failing to properly address alcohol
use in terms of how it can worsen disease states and interact with medications.
As mentioned previously, current literature suggests that patients may be more
receptive to having a conversation with their healthcare provider about alcohol use if it is
framed in terms of negative interactions. This policy change could be easily implemented in
pharmacy school curriculum, as it would not require a complete reworking of the material,
rather additional education on how to address potential interactions.
In conclusion, alcohol use with concurrent alcohol-interactive medications and disease
states can lead to serious health problems in older adults. This study identified a prevalent issue
but necessitates further research to assess follow up and additional metrics regarding these
interactions. In addition, ways to better intervene in these patients’ health, such as a
pharmacist-led protocol and reworking pharmacy student curriculum, should be investigated.
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Appendix
List of meds looked at and how they interact with alcohol
Medication
alprazolam
amiloride
amiodarone
amitriptyline
amlodipine
amphetamine/dex
troamphetamine
aspirin
atenolol
benazepril
bisoprolol
bupropion
buspirone
carisoprodol
carvedilol
celecoxib
chlorpheniramine
chlorthalidone
citalopram
clonazepam
clonidine
cyclobenzaprine
diclofenac
diclofenac gel
diphenhydramine
duloxetine
escitalopram
fexofenadine
fluoxetine
furosemide
gabapentin
glimiperide
glipizide
hydralazine

Count
2
1
1
3
15
1
16
3
2
1
4
2
1
3
2
1
1
2
1
1
3
3
1
4
2
3
2
1
2
9
1
1
1
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hydrochlorothiazi
de
hydrocodone
hydroxyzine
ibuprofen
imipramine
indomethacin
insulin
irbesartan
isocarboxazid
lisinopril
lorazepam
losartan
meloxicam
memantine
methotrexate
metoprolol
nabumetone
nadolol
naproxen
nifedipine
olmesartan
oxcarbazepine
paroxetine
pramipexole
prednisolone
pregabalin
propranolol
ranitidine
ranolazine
rivaroxaban
sertraline
spironolactone
sulindac
temazepam
tizanidine
topiramate
tramadol
trazodone
triamterene

11
1
2
3
1
1
3
2
1
9
1
11
6
1
1
14
1
1
3
1
1
1
4
1
1
4
2
11
1
2
2
2
1
1
1
1
3
1
1
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valsartan
venlafaxine
verapamil
vortioxetine
zolpidem
Grand Total

5
1
1
1
2
221
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